In a 23-year-old female with hemoglobin 8.7 g/dL, mean corpuscular volume 64 fL, normal iron studies, mildly elevated alanine aminotransferase (ALT) and aspartate aminotransferase (AST), and cholelithiasis on abdominal ultrasound, what is the likely cause and how should further evaluation be pursued?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 11, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Likely Diagnosis: Thalassemia Trait with Possible Hemolytic Component

This 23-year-old female most likely has thalassemia trait (beta-thalassemia minor) given the microcytic anemia (MCV 64 fL) with normal iron studies, and the presence of cholelithiasis at a young age suggests chronic hemolysis with pigment stone formation. 1

Clinical Reasoning

Anemia Classification

The patient presents with:

  • Microcytic anemia (MCV 64 fL, normal >80 fL) with Hb 8.7 g/dL
  • Normal iron studies - this is the critical distinguishing feature

According to the morphologic approach to anemia evaluation, microcytic anemia (<80 fL) is most commonly caused by iron deficiency, but other causes include thalassemia, anemia of chronic disease, and sideroblastic anemia 1. When iron studies are normal in the setting of microcytic anemia, thalassemia becomes the primary consideration, especially in a young patient.

Key Diagnostic Features Supporting Thalassemia

  1. Severe microcytosis (MCV 64) - The degree of microcytosis is disproportionate to the anemia severity, which is characteristic of thalassemia trait
  2. Normal iron parameters - Rules out iron deficiency anemia as the cause
  3. Young age with cholelithiasis - Suggests chronic hemolysis leading to pigment (bilirubin) gallstone formation
  4. Mildly elevated transaminases (ALT 76, AST 57) - May reflect hepatic iron deposition or mild hemolysis-related changes

The cholelithiasis in a 23-year-old is particularly telling, as chronic hemolytic conditions (including thalassemia) lead to increased bilirubin production and pigment stone formation 2.

Immediate Workup Required

First-Line Essential Tests

  1. Complete Blood Count with peripheral blood smear review 1

    • Look for: target cells, basophilic stippling, nucleated RBCs
    • Confirm microcytosis and assess RBC morphology
  2. Reticulocyte count/index 1

    • High reticulocyte index suggests hemolysis or blood loss
    • In thalassemia trait, reticulocyte count is typically normal to mildly elevated
  3. Hemoglobin electrophoresis 3

    • This is the definitive test for thalassemia
    • Will show elevated HbA2 (>3.5%) in beta-thalassemia trait
    • May show elevated HbF
  4. Indirect vs direct bilirubin fractionation 4

    • Elevated indirect (unconjugated) bilirubin confirms hemolysis
    • The cholelithiasis suggests chronic unconjugated hyperbilirubinemia
  5. Lactate dehydrogenase (LDH) and haptoglobin 2

    • Elevated LDH and low/absent haptoglobin confirm hemolysis
    • These markers distinguish hemolytic from non-hemolytic causes

Additional Evaluation for Liver Enzymes

The mildly elevated transaminases (ALT 76, AST 57) require consideration of:

  • Hemochromatosis screening (serum ferritin, transferrin saturation) 4

    • Though iron studies are reported as "normal," confirm transferrin saturation and ferritin specifically
    • Thalassemia can paradoxically lead to iron overload despite microcytosis
  • Viral hepatitis serologies (HBsAg, anti-HCV) 4

    • Rule out concurrent viral hepatitis
  • Autoimmune markers if indicated (ANA, ASMA, immunoglobulins) 4

Addressing the Cholelithiasis

The gallstones are likely pigment stones secondary to chronic hemolysis. Management depends on symptoms:

  • If asymptomatic: Observation is appropriate
  • If symptomatic (biliary colic, cholecystitis): Surgical consultation for cholecystectomy
  • The presence of cholelithiasis does NOT explain the anemia or liver enzyme elevation in isolation 5

Critical Pitfalls to Avoid

  1. Do not assume iron deficiency based solely on microcytosis - Normal iron studies exclude this diagnosis 1

  2. Do not attribute the anemia to "anemia of chronic disease" from liver dysfunction - The MCV is too low and the pattern doesn't fit 3

  3. Do not overlook hemolysis - The combination of microcytic anemia, cholelithiasis at young age, and mildly elevated transaminases suggests chronic hemolysis 2

  4. Consider combined deficiencies - Patients with thalassemia can develop concurrent iron deficiency from menstrual losses, which would worsen the anemia 3

Definitive Diagnostic Algorithm

Step 1: Obtain hemoglobin electrophoresis immediately - this will confirm or exclude thalassemia trait

Step 2: Assess for hemolysis with reticulocyte count, LDH, haptoglobin, and indirect bilirubin

Step 3: If hemoglobin electrophoresis is diagnostic for thalassemia trait:

  • Provide genetic counseling
  • Screen family members
  • Avoid unnecessary iron supplementation
  • Monitor for complications (iron overload if receiving transfusions)

Step 4: If hemoglobin electrophoresis is normal, consider:

  • Sideroblastic anemia (rare)
  • Lead toxicity (rare) 3
  • Other hemoglobinopathies requiring specialized testing

Step 5: Address the cholelithiasis based on symptoms and surgical evaluation

Expected Outcome

If thalassemia trait is confirmed, this patient requires genetic counseling, avoidance of iron supplementation, and monitoring but typically has normal life expectancy and quality of life. The cholelithiasis may require surgical management if symptomatic. The mildly elevated liver enzymes should normalize or remain stable with appropriate management of any underlying hemolysis.

Related Questions

What additional laboratory tests are indicated for a 33-year-old woman with mildly elevated total bilirubin, mildly elevated alanine aminotransferase, high ferritin, high serum iron, and borderline high triglycerides?
In a 44-year-old patient with alkaline phosphatase 125 U/L, aspartate aminotransferase (AST) 19 U/L, alanine aminotransferase (ALT) 35 U/L, and total bilirubin 0.4 mg/dL, what is the clinical significance of these liver function test results?
In a 43-year-old man taking atorvastatin 20 mg daily who has elevated alkaline phosphatase, alanine aminotransferase, aspartate aminotransferase, total bilirubin, and gamma‑glutamyl transferase, what is the differential diagnosis?
What diagnostic work‑up is indicated for a 57‑year‑old woman presenting with abdominal pain and laboratory evidence of markedly elevated transaminases, hyperbilirubinemia, cholestatic alkaline phosphatase elevation, and Enterobacter bacteremia?
How should a 68-year-old woman with intermittent epigastric pain and markedly elevated AST (634 U/L) and ALT (793 U/L) be evaluated and managed?
What is the appropriate acute management for a swollen left hand sustained in a fight (including pain control, imaging, and splinting) and for a tooth bite injury to the opponent's mouth (including wound care and antibiotic prophylaxis)?
What bevel orientation should be used when inserting a needle for a digital nerve block to avoid the digital nerve and artery?
In a 49-year-old woman with long-standing arthritis, negative erythrocyte sedimentation rate, C-reactive protein, and rheumatoid factor but a positive antinuclear antibody titer of 1:160, what further evaluation and management steps are recommended?
What does a dilated common bile duct indicate?
What is the appropriate dose and duration of cephalexin (Keflex) for cellulitis in a patient with a glomerular filtration rate of 51 mL/min?
Can nitroglycerin be administered by infusion in a patient with nephrotic syndrome?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.